---
date created: 2024-11-16
dg-publish: true
tags:
  - meds
---
**Class:**
- Acetylcholinesterase Inhibitor

**Mechanism of Action (MOA):**
- Inhibits both acetylcholinesterase and butyrylcholinesterase, increasing acetylcholine levels in the brain, which may help reduce symptoms of Alzheimer's disease and Parkinson's disease dementia.

**Indications/Uses:**
- Mild to moderate Alzheimer's disease
- Parkinson's disease dementia

**Side Effects:**
- Nausea
- Vomiting
- Diarrhea
- Dizziness
- Anorexia

**Adverse Effects:**
- Bradycardia
- Gastrointestinal bleeding
- Seizures (rare)
- Severe allergic reactions (rare)

**Nursing Teaching and Implications:**
- Advise taking with food to reduce gastrointestinal side effects.
- Monitor for weight loss and signs of dehydration.
- Educate about the importance of adherence to the dosing schedule.
- Assess for improvement in cognitive function over time.

**Contraindications:**
- Known hypersensitivity to rivastigmine or carbamate derivatives